Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 7, 2012; 18(17): 2035-2042
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2035
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2035
Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells
Lei Jiang, Laboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, Zhejiang Province, China
Yiu-Kay Lai, Department of Life Science, National Tsing Hua University, Hsinchu 30013, Taiwan
Jin-Fang Zhang, Chu-Yan Chan, Ming-Liang He, Hsiang-Fu Kung, Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin 999077, Hong Kong, China
Gang Lu, Marie CM Lin, Brain Tumor Centre and Division of Neurosurgery, Department of Surgery, The Chinese University of Hong Kong, Shatin 999077, Hong Kong, China
Ji-Cheng Li, Institute of Cell Biology, Zhejiang University, Hangzhou 310058, Zhejiang Province, China
Author contributions: Jiang L, Chan CY, Lin MCM, He ML, Li JC and Kung HF designed the research; Jiang L, Zhang JF and Lu G performed the research; Jiang L, Lai YK, Lin MCM, He ML, Li JC and Kung HF analyzed the data; Jiang L, Lai YK and Chan CY wrote the paper.
Supported by Hong Kong Research Grant Council, No. 467109, 467507; the Scientific Research Fund of Zhejiang Provincial Education Department, No. Y200906317; the Wenzhou Science and Technology Bureau Program, No. Y20100017;Qianjiang Talents Project of Zhejiang Province, No.2011R10058
Correspondence to: Hsiang-Fu Kung, Professor, Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin 999077, Hong Kong, China. hkung@cuhk.edu.hk
Telephone: +852-26037743 Fax: +852-29944988
Received: April 7, 2011
Revised: November 12, 2011
Accepted: February 26, 2012
Published online: May 7, 2012
Revised: November 12, 2011
Accepted: February 26, 2012
Published online: May 7, 2012
Core Tip